David Pierre-Marie, Onno Julien, Pourraz Jessica, Ahmad Khan Faiz
Faculty of Pharmacy, University of Montréal, Montréal, Canada.
OBVIA, Observatoire sur les impacts sociétaux de l'IA et du numérique, Québec, Canada.
Digit Health. 2024 Apr 16;10:20552076241239778. doi: 10.1177/20552076241239778. eCollection 2024 Jan-Dec.
Computer-aided detection algorithms based on artificial intelligence are increasingly being tested and used as a means for detecting tuberculosis in countries where the epidemic is still present. Computer-aided detection tools are often presented as a global solution that can be deployed in all the geographical areas concerned by tuberculosis, but at the same time, they need to be adjusted and calibrated according to local populations' characteristics. The aim of this article is to analyze the tensions between the standardization of computer-aided detection algorithms and their local adaptation and the political issues associated with these tensions. We undertook a qualitative analysis of practices associated with tuberculosis detection algorithms in different contexts, contrasting the perspectives of various stakeholders. Algorithms embed the promise of standardization through automation and the bypassing of variable human expertise such as that of radiologists, they are nonetheless objects of local practices that we have characterized as "tweaking." This work of tweaking reveals how the technology is situated but also the many concerns of the users and workers (insertion in care, control over infrastructure, and political ownership). This should be better considered to truly make computer-aided detection innovative tools for tuberculosis management in global health.
在结核病疫情仍存在的国家,基于人工智能的计算机辅助检测算法正越来越多地得到测试并被用作检测结核病的手段。计算机辅助检测工具常常被视为一种可部署在所有受结核病影响地理区域的全球解决方案,但与此同时,它们需要根据当地人群的特征进行调整和校准。本文旨在分析计算机辅助检测算法的标准化与其本地化适应之间的矛盾,以及与这些矛盾相关的政治问题。我们对不同背景下与结核病检测算法相关的实践进行了定性分析,对比了不同利益相关者的观点。算法通过自动化以及绕过诸如放射科医生等可变的人类专业知识,蕴含着标准化的前景,但它们仍是我们所描述为“调整”的本地化实践的对象。这种调整工作揭示了技术的实际情况,也揭示了用户和工作人员的诸多担忧(融入医疗、对基础设施的控制以及政治所有权)。为了使计算机辅助检测真正成为全球卫生领域结核病管理的创新工具,对此应予以更好的考虑。